Eucomed takes the initiative on phthalates
This article was originally published in RAJ Devices
With little over seven months to go before the directive that revises the European Union’s medical device directives (Directive
You may also be interested in...
UK health minister Baroness Blackwood will introduce the new UK Medicines and Medical Devices Bill before Parliament today, just before the House of Commons goes into recess. The government wants new legislation for devices and medicines in place before the end of the Brexit transition period.
EU medical device consultant Trevor Lewis takes note of the recent, if belated, progress towards the building of the post-MDR playing field for medical device companies in Europe, but calls political decision-makers and economic operators to account: getting it right is nothing short of a matter of life and death, he tells In Vivo.
Cryoport is a unique company in its niche – supporting regenerative medicine clinical trials and commercial products with cold chain logistics – and has designs on becoming a full supply chain partner for the biopharma industry. CEO Jerry Shelton explained the company’s current role and future plans to In Vivo during the recent Jefferies Healthcare conference.